These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18713047)

  • 1. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front.
    Kollef MH
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S3-13. PubMed ID: 18713047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting.
    Buising KL; Thursky KA; Robertson MB; Black JF; Street AC; Richards MJ; Brown GV
    J Antimicrob Chemother; 2008 Sep; 62(3):608-16. PubMed ID: 18550680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms.
    Niederman MS
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections fails.
    Sundqvist M; Kahlmeter G
    J Antimicrob Chemother; 2009 Aug; 64(2):227-8. PubMed ID: 19454527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections.
    Mohr JF
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S41-51. PubMed ID: 18713049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The empiric treatment of nosocomial intra-abdominal infections.
    Dupont H
    Int J Infect Dis; 2007 May; 11 Suppl 1():S1-6. PubMed ID: 17603948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When "S" does not mean success: the importance of choice of antibiotic and dose on clinical and economic outcomes of severe infection.
    Gillespie EL; Kuti JL; Nicolau DP
    Conn Med; 2005 Apr; 69(4):203-10. PubMed ID: 15926635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global resistance trends and the potential impact on empirical therapy.
    Isturiz R
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S201-6. PubMed ID: 19134520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new treatment paradigm and the role of carbapenems.
    Masterton RG
    Int J Antimicrob Agents; 2009 Feb; 33(2):105-110. PubMed ID: 18848436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data.
    Deresinski S
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S177-83. PubMed ID: 17712744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of severe bacterial infections.
    Esposito S; Leone S; Noviello S
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):593-600. PubMed ID: 16107198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial stewardship: application in the intensive care unit.
    Owens RC
    Infect Dis Clin North Am; 2009 Sep; 23(3):683-702. PubMed ID: 19665090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series.
    Hitchcock J; Jepson AP; Main J; Wickens HJ
    J Antimicrob Chemother; 2009 Sep; 64(3):630-4. PubMed ID: 19549671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory.
    Eveillard M; Lemarié C; Cottin J; Hitoto H; Mahaza C; Kempf M; Joly-Guillou ML
    Clin Microbiol Infect; 2010 Aug; 16(8):1084-9. PubMed ID: 19732085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early antibiotic treatment failure.
    Sánchez García M
    Int J Antimicrob Agents; 2009 Aug; 34 Suppl 3():S14-9. PubMed ID: 19596109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of increased antibacterial consumption and change in pattern of antibacterial use in Danish hospitals.
    Jensen US; Skjøt-Rasmussen L; Olsen SS; Frimodt-Møller N; Hammerum AM;
    J Antimicrob Chemother; 2009 Apr; 63(4):812-5. PubMed ID: 19240071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.